158 related articles for article (PubMed ID: 25868729)
1. A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3).
van Wijk XM; Lawrence R; Thijssen VL; van den Broek SA; Troost R; van Scherpenzeel M; Naidu N; Oosterhof A; Griffioen AW; Lefeber DJ; van Delft FL; van Kuppevelt TH
FASEB J; 2015 Jul; 29(7):2993-3002. PubMed ID: 25868729
[TBL] [Abstract][Full Text] [Related]
2. Giardia lamblia: increased UDP-N-acetyl-D-glucosamine and N-acetyl-D-galactosamine transferase activities during encystation.
Das S; Gillin FD
Exp Parasitol; 1996 Jun; 83(1):19-29. PubMed ID: 8654548
[TBL] [Abstract][Full Text] [Related]
3. Amino sugar phosphate levels in Giardia change during cyst wall formation.
Sener K; Shen Z; Newburg DS; Jarroll EL
Microbiology (Reading); 2004 May; 150(Pt 5):1225-1230. PubMed ID: 15133084
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of a series of 2-acetamido-2-deoxy-D-glucose analogs towards cellular glycosaminoglycan and protein synthesis in vitro.
Berkin A; Szarek WA; Kisilevsky R
Glycoconj J; 2005 Nov; 22(7-9):443-51. PubMed ID: 16311889
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Direct Biosynthetic Pathway for UDP-
Dadashipour M; Iwamoto M; Hossain MM; Akutsu JI; Zhang Z; Kawarabayasi Y
J Bacteriol; 2018 May; 200(10):. PubMed ID: 29507091
[TBL] [Abstract][Full Text] [Related]
6. Rhodamine B and 2-acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-fluoro-D-glucopyranose (F-GlcNAc) inhibit chondroitin/dermatan and keratan sulphate synthesis by different mechanisms in bovine chondrocytes.
Derrick-Roberts AL; Marais W; Byers S
Mol Genet Metab; 2012 Jun; 106(2):214-20. PubMed ID: 22546219
[TBL] [Abstract][Full Text] [Related]
7. A 17-amino acid insert changes UDP-N-acetylhexosamine pyrophosphorylase specificity from UDP-GalNAc to UDP-GlcNAc.
Wang-Gillam A; Pastuszak I; Elbein AD
J Biol Chem; 1998 Oct; 273(42):27055-7. PubMed ID: 9765219
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells.
Pan X; Wilson M; Mirbahai L; McConville C; Arvanitis TN; Griffin JL; Kauppinen RA; Peet AC
J Proteome Res; 2011 Aug; 10(8):3493-500. PubMed ID: 21644796
[TBL] [Abstract][Full Text] [Related]
9. The effect of penultimate N-acetylgalactosamine 4-sulfate on chondroitin chain elongation.
Cogburn JN; Silbert JE
Carbohydr Res; 1986 Aug; 151():207-12. PubMed ID: 3094936
[TBL] [Abstract][Full Text] [Related]
10. Selective analysis of intracellular UDP-GlcNAc and UDP-GalNAc by hydrophilic interaction liquid chromatography-mass spectrometry.
Sugiyama C; Furusho A; Todoroki K; Sugiyama E
Anal Methods; 2024 Mar; 16(12):1821-1825. PubMed ID: 38433563
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic route to preparative-scale synthesis of UDP-GlcNAc/GalNAc, their analogues and GDP-fucose.
Zhao G; Guan W; Cai L; Wang PG
Nat Protoc; 2010 Apr; 5(4):636-46. PubMed ID: 20224564
[TBL] [Abstract][Full Text] [Related]
12. Arabidopsis ROCK1 transports UDP-GlcNAc/UDP-GalNAc and regulates ER protein quality control and cytokinin activity.
Niemann MC; Bartrina I; Ashikov A; Weber H; Novák O; Spíchal L; Strnad M; Strasser R; Bakker H; Schmülling T; Werner T
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):291-6. PubMed ID: 25535363
[TBL] [Abstract][Full Text] [Related]
13. Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes.
Pouwels MJ; Span PN; Tack CJ; Olthaar AJ; Sweep CG; van Engelen BG; de Jong JG; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2002 Nov; 87(11):5179-84. PubMed ID: 12414889
[TBL] [Abstract][Full Text] [Related]
14. Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis.
van Wijk XM; Thijssen VL; Lawrence R; van den Broek SA; Dona M; Naidu N; Oosterhof A; van de Westerlo EM; Kusters LJ; Khaled Y; Jokela TA; Nowak-Sliwinska P; Kremer H; Stringer SE; Griffioen AW; van Wijk E; van Delft FL; van Kuppevelt TH
ACS Chem Biol; 2013 Oct; 8(10):2331-8. PubMed ID: 23972127
[TBL] [Abstract][Full Text] [Related]
15. Formation of UDP-2-acetamido-2-deoxy-L-galactose and UDP-2-acetamido-2-deoxy-L-galacturonic acid by Pseudomonas aeruginosa.
Singh S; Singh U; Hogan SE; Feingold DS
J Bacteriol; 1990 Jan; 172(1):299-304. PubMed ID: 2152905
[TBL] [Abstract][Full Text] [Related]
16. A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro.
van Wijk XM; Oosterhof A; van den Broek SA; Griffioen AW; ten Dam GB; Rutjes FP; van Delft FL; van Kuppevelt TH
Exp Cell Res; 2010 Sep; 316(15):2504-12. PubMed ID: 20433828
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of aryl azide derivatives of UDP-GlcNAc and UDP-GalNAc and their use for the affinity labeling of glycosyltransferases and the UDP-HexNAc pyrophosphorylase.
Zeng Y; Shabalin Y; Szumilo T; Pastuszak I; Drake RR; Elbein AD
Anal Biochem; 1996 Jul; 239(1):99-106. PubMed ID: 8660631
[TBL] [Abstract][Full Text] [Related]
18. MS analysis of chondroitin polymerization: effects of Mn2+ ions on the stability of UDP-sugars and chondroitin synthesis.
Sugiura N; Shimokata S; Watanabe H; Kimata K
Anal Biochem; 2007 Jun; 365(1):62-73. PubMed ID: 17395146
[TBL] [Abstract][Full Text] [Related]
19. Mass isotopomer analysis of metabolically labeled nucleotide sugars and N- and O-glycans for tracing nucleotide sugar metabolisms.
Nakajima K; Ito E; Ohtsubo K; Shirato K; Takamiya R; Kitazume S; Angata T; Taniguchi N
Mol Cell Proteomics; 2013 Sep; 12(9):2468-80. PubMed ID: 23720760
[TBL] [Abstract][Full Text] [Related]
20. Metabolic glycoengineering through the mammalian GalNAc salvage pathway.
Pouilly S; Piller V; Piller F
FEBS J; 2012 Feb; 279(4):586-98. PubMed ID: 22151230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
